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Original Article
Case–Control Research Study
of Auto-Brewery Syndrome
Barbara Jean Cordell, PhD, RN, AHN-BC1 ,
Anup Kanodia, MD, MPH, IFMCP2, and Gregory K Miller, PhD3
Abstract
Background: Auto-brewery syndrome (ABS), also known as Gut Fermentation Syndrome and Endogenous Ethanol
Fermentation, is afflicting people worldwide, but little is known about ABS patients’ demographics, health history, lifestyle
factors, and diet.
Method: We conducted a broad-based case–control survey study on 52 patients known to have a diagnosis of ABS and
their household members. The research compares the symptomatic group (N¼ 28) to the asymptomatic group (N¼ 18)
regarding lifestyle and health, diet, and medical history.
Results:With a response rate of 88% and using rank-sum tests, the data demonstrate that patients with ABS have significant
differences compared to people without ABS in lower quality bowel movements (P¼.048), more frequent bowel move-
ments (P¼.038), more reports of malodorous breath (P¼.0001), and self-classify as having poorer health (P¼.009).
Furthermore, participants with ABS consume more water (P¼.038), consume less tea and coffee (P¼.033), eat fewer
dairy products (P¼.0185), eat less candy (P¼.032), eat out less and rely on food prepared at home (P¼.043), have more
aversion to starch (P¼.008), and have more food sensitivities (P¼.043) than the group without ABS. The ABS group also
reports more diarrhea (P¼.048), higher amounts of yeast in their gastrointestinal tract (P¼.015), and using acne medication
for a longer time (P¼.037) than the control group.
Conclusion: Patients with ABS have significant differences in their lifestyle and health, diet, and medical history compared
to non-ABS participants and these differences warrant further research.
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Introduction and Review of Literature
Auto-brewery syndrome (ABS), also known as Gut
Fermentation Syndrome and Endogenous Ethanol
Fermentation, has long been recognized in the literature.
The earliest cases were reported in Japan in the 1950s to
1970s1–3 and continue to be documented, researched,
and reported into the current century not only in
Japan but also in Great Britain,4–6 Egypt,7 and the
United States.8,9 In 2016, authors from the Mayo
Clinic stated “. . . auto-brewery may be considered in a
patient with chronic obstruction or hypomotility pre-
senting with elevated serum ethanol levels in the setting
of high carbohydrate intake.”10 Despite the many
articles describing the syndrome, relatively little is
known about the underlying mechanisms, let alone
the cause.
We know the microbiome plays a large role in health
and illness. When the microbiome is disturbed, for
example, through diet, immune dysfunction and disease
processes can result such as nonalcoholic fatty liver
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disease and cardiovascular disease.11 The gut micro-
biome has been implicated in metabolic disease,12
inflammatory bowel disease,13–16 and obesity.17
The human microbiome has been studied extensively
for many years now, but science is just beginning to
understand the fungal microbiota known as the myco-
biome.18 Of the thousands of different microbes in an
individual’s gut, an estimate of less than 0.1% is consid-
ered rare, and fungi belong to this “rare biosphere.”19
Most of the reports of fungal infections in the medical
literature focus on yeast and fungal overgrowth when
the patient is immune-compromised, and many medical
professionals dismiss the idea that an otherwise healthy
individual could develop a serious fungemia; however,
the pathology of ABS is believed to be an overgrowth of
yeast in the intestines known as “fungal-type dysbiosis of
the gut” that ferments some carbohydrates into ethanol
and may mimic food allergy or intolerance.20
ABS certainly seems to be more prevalent in patients
with comorbidities such as Crohn disease,10 short bowel
syndrome,21 and obesity-related liver disease,22 but there
is a growing contingent of patients suffering with other-
wise unexplained intoxication. People suffering from
ABS universally have a demonstrated overgrowth of
intestinal yeast and often have signs of yeast infections
in other systems (integumentary, nail beds, etc.), but the
actual causes and treatments are poorly understood.
Some patients respond to dietary changes alone, while
others require antifungal medication, dietary changes,
supplements, lifestyle modifications (sufficient sleep,
decreasing stress, nonexcessive exercising), and/or pro-
biotics, while a small minority of patients do not seem to
respond to any of the mentioned treatments.9
The purpose of the current research project is to iden-
tify the health history and lifestyle factors of subjects
diagnosed and/or experiencing symptoms of ABS and
to compare those factors in subjects of 2 control
groups without symptoms of ABS. The control group
is composed of people without symptoms of ABS who
are living with someone who has symptoms of ABS.
Methods
Survey
A 78-item survey titled the Gut Fermentation Survey
(GFS) was developed using questions from the
American Gut Project23 as well as questions from
other well-known survey sources which offered validity
and reliability for the questions. The American Gut
Project is a crowd-funded science project to compare
the gut microbiomes of average American citizens with
other groups from the United States and around the
world. As part of the project, an extensive diet and life-
style questionnaire related to the gut microbiome is
administered. We used their questions except where
noted otherwise. Anyone wishing to obtain a complete
copy of our questionnaire and methods may contact the
corresponding author.
Questions 1 to 8 are demographic questions patterned
after the Integrated Postsecondary Education Data
System from the National Center for Education
Statistics of the Department of Education.24
Questions 9 to 11 ask about diagnosis and symptoms
of ABS and serve to divide the group of respondents into
the ABS group (those with diagnosis and/or symptoms)
and the control group (those without symptoms).
Questions 12 to 37 query Lifestyle and Health factors
such as living arrangements, dental care, tobacco use,
bowel habits, sleep habits, and pets. The tobacco ques-
tions come from the World Health Organization,25
bowel habit questions from the American Gut
Project,23 and the sleep questions from the Mini-Sleep
Questionnaire.26
Questions 38 to 55 ask about General Diet
Information such as type of diet followed, amount and
type of liquids consumed, alcohol consumption, and
food allergies. The dietary questions were taken from
the American Gut Project23 except for the questions on
alcohol use which came from the National Institute on
Alcohol Abuse and Alcoholism.27
Questions 56 to 72 concern the individual’s Health
History such as method of birth, whether the subject
was breast-fed or given formula and how long, past sur-
geries, medical conditions past and present, as well as
nonfood allergies. The questions on breastfeeding came
from the survey methods of breastfeeding from the
Centers for Disease Control and Prevention.28
Questions 73 to 77 regarded medications and supple-
ments being taken, and question 78 asks if the respon-
dent would be willing to be contacted concerning future
research opportunities.
Study Design
A case–control study was chosen as the method to iden-
tify factors which individuals with symptoms of ABS
might have in higher frequency than those without
ABS. Our study was approved by the Institutional
Review Board at Panola College in Carthage, TX.
Subjects
We offered the GFS survey to 52 patients known to the
authors to have a diagnosis of ABS and their significant
others in the household. Potential participants were ini-
tially contacted via e-mail and offered a $25 gift card as
an incentive to complete the survey. After 30 days, those
who had not responded were again contacted by e-mail
and encouraged to participate. Forty-six of the people
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contacted digitally accepted the informed consent docu-
ment and completed the survey. Of the 46 respondents,
28 had a history of ABS and the other 18 respondents
formed the control group.
Statistical Analysis
The study compared the GFS responses of people that
have a history of ABS (N¼ 28) to the responses of those
without diagnosis or symptom history (N¼ 18). For
survey questions that facilitate a comparison between
the symptom and control group, 2 by c contingency
tables were created to tabulate question responses and
test for row homogeneity using a permutation chi-square
test where the data were categorical. All such permuta-
tion chi-square tests were calculated using StatXact by
Cytel in Cambridge, MA. Additional permutation
Kruskal–Wallis tests reduced to rank-sum tests (also
known as Mann–Whitney Wilcoxon rank-sum tests)
were used to analyze row homogeneity between
symptom and control groups in the cases where survey
questions generate ordinal responses.
Results
Demographics
The demographics of the 46 participants are detailed in
Table 1. Of the 46 participants, 28 were in the ABS
group and 18 were in the non-ABS group. All partici-
pants were older than 18 years as verified in the informed
consent. Of the 28 participants who had ABS, 16 were
male and 12 were female. The majority were born in the
United States (26), 1 was born in South America, and 1
in Europe. In the group of 18 non-ABS, 14 were female
and 4 were male with the majority born in the United
States (16), 1 in Ethiopia, and 1 in Europe.
Nearly all the participants have spent most of their
lives in the United States with 1 in the ABS group living
most of their life in Europe and 1 in the non-ABS group
living most of their life in Ethiopia.
One person in the ABS group identified as American
Indian or Alaskan Native with the remainder identifying
as White; in the non-ABS group, 14 people identified as
White, 1 as American Indian or Alaskan Native, 1 as
Black or African American, and 2 as Asian.
Of the 28 ABS participants, 3 identified as Hispanic
or Latino, 1 did not answer, and the remaining 24 select-
ed Not Hispanic or Latino. In the non-ABS group, 1 did
not answer, and the remaining 17 selected Not Hispanic
or Latino.
Lifestyle and Health
The differences found in this section of the survey per-
tain uniquely to bowel movement frequency and quality.
The P values for these 2 questions are each .04 with
patients in the ABS group reporting a higher frequency
and lower quality of bowel movements than the control
group. Also, those with ABS history are frequently told
their breath is odorous (P¼ .0001) and self-classify as
having poorer overall health than their peers in the con-
trol group (P¼ .009).
General Diet Information
Here, the ABS patients consume more water (P¼ .038)
and less tea and coffee (P¼ .033) than the control group
and eat dairy products and candy at a lesser rate than
the control group (P¼ .018 and .032, respectively).
Those with a history of ABS tend to eat out less and
rely more on food prepared at home (P¼ .043) and have
an aversion to starch (P¼ .0008).
Table 1. Demographics of Respondents.
Group ABS (N¼ 28) Non-ABS (N¼ 18)
Sex F¼ 12; M¼ 16 F¼ 14; M¼ 4
Continent where born 1¼ South America
1¼ Europe
26¼United States
1¼ Ethiopia
1¼ Europe
16¼United States
Continent where lived
most of life
1¼ Europe
27¼United States
1¼ Ethiopia
17¼United States
Race 1¼American Indian or Alaskan Native
27¼White
1¼American Indian or Alaskan Native
1¼Black or African American
2¼Asian
14¼White
Ethnicity 3¼Hispanic or Latino
1¼Did not answer
24¼Not Hispanic or Latino
1¼Did not answer
17¼Not Hispanic or Latino
Abbreviation: ABS, auto-brewery syndrome.
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Health History
Finally, the “Health History” section of the survey
revealed those with ABS symptoms experience food sen-
sitivities at a higher rate than those in the control group
(P¼ .043), diarrhea at a higher rate (P¼ .016), and yeast
in their gastrointestinal (GI) tract at a higher rate
(P¼ .015). Regarding medications, patients experiencing
symptoms of ABS who need acne medication use it for a
longer period than control group peers needing such
medication (P¼ .03).
The results of the questions showing differences
between the ABS group and the control group, for life-
style and health, general diet information, and health
history are detailed in Table 2.
Discussion
Our study group (N¼ 28) consisted predominantly of
white, non-Hispanic males born in the United States.
This is similar to other recent case studies of people
with ABS8–10,21 with the exception of the older case stud-
ies written in Japan1–3 where the subjects were presum-
ably of Japanese descent even though it was not
specified. In 1998, a survey of 25 patients with fungal-
type dysbiosis of the gut was conducted in London,
England, that included 19 females and 6 males but did
not identify race or ethnicity20 and only looked at yeast
infections, not fermentation. Although most of the
people with ABS who have contacted us are males, it
may be that female caregivers are more willing to
reach out for help and information.
We discovered that people with symptoms of ABS
have lower quality and more frequent bowel movements
described as diarrhea than the control group. No other
research studies of people with ABS were found that
looked at bowel function although several case studies
of ABS described accompanying GI symptoms such as
diarrhea, bloating, abdominal discomfort, nausea, and
vomiting.3,9,10,20
The strongest finding in our study is that the breath of
ABS sufferers is reported as malodorous more often
than the control group. A previous study that compared
ethanol producers and nonproducers demonstrated no
significant differences in lactulose breath hydrogen;29
however, at least 1 case study of ABS reports odor of
alcohol on the breath.3 Other ABS case studies report
negative breath tests during a GI workup,8,9 but the
workups were not conducted while the patients were
actively fermenting.
Anecdotally, family members report the smell, not as
alcohol, but as somewhat fruity and foul. Others relate a
smell more like a “hangover breath” than intoxication
and several describe the smell as being similar to but
different from diabetic ketoacidosis breath. Several
breath studies have been conducted for irritable bowel
syndrome and small intestinal bacterial overgrowth
Table 2. Lifestyle, Diet, and Health History Survey Questions With Significant Differences in Data.
Question
No.
Shortened
Question P Interpretation
31 Bowel movement
per day
.0378 Those with GFS symptoms have more frequent bowel movements.
32 Bowel quality .0477 Those with GFS symptoms have more frequent diarrhea.
34 Breath odor <.0001 Those with GFS symptoms have people state they have breath odor at a far
greater rate than those without symptoms.
37 Rate your health .0090 Those with GFS symptoms rate themselves in worse health at a greater rate
than those without symptoms.
39 Water consumption .0380 Those with GFS symptoms consume 64þ ounces of water per day at a higher rate.
45 Tea/Coffee .0334 Those with GFS symptoms consume tea/coffee at a less rate.
50 Dairy .0185 Those with GFS symptoms tend to eat dairy products at a less rate
than those without symptoms.
52 Starch .0008 Those with GFS symptoms tend to eat starch at much less rate than
those without symptoms.
53 Eat out .0432 Those with GFS symptoms eat food prepared away from home at a less rate.
54 Eat candy .0321 Those with GFS symptoms eat chocolate and candy at a less rate.
69 Food sensitivity .0433 Those with GFS symptoms have been tested and removed offending foods
at a higher rate.
70a Yeast in GI tract .0153 Those with GFS symptoms have had intestinal fungal overgrowth at a higher rate
than those without symptoms.
74 How long medications
for acne
.0373 Those with GFS symptoms who need medication for acne have taken it longer.
Abbreviations: GFS, Gut Fermentation Survey; GI, gastrointestinal.
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(SIBO) that agree there are changes in breath for lactose,
lactulose, fructose, and so on.30,31
The data revealed the overall health of sufferers is
poorer than the control group (P¼ .009). This is similar
to Eaton’s study of 30 patients with ABS who were
found to have poorer health as measured by deficiency
of B vitamins, zinc, and magnesium.5 Additional
research points to concomitant health issues to ABS
such as chronic fatigue syndrome, eczema, and chronic
vaginal yeast infection.2,5 Other studies support that gut
dysbiosis, which may be an underlying cause of ABS, is
implicated in inflammatory bowel disorders such as
Irritable Bowel Syndrome (IBS) and Crohn’s dis-
ease.13,14,32 Case studies point to ABS as a development
from an underlying disorder such as short bowel syn-
drome or Crohn’s disease.10,21,33
Another related question on the research GFS asked
the respondents to check all GI illnesses they had from a
list of 18 illnesses, such as Celiac disease, Diverticular
disease, SIBO, and Acid Reflux, and 24 of the 28 symp-
tomatic respondents checked at least 1 illness while only
11 of the 18 in the control group checked at least 1.
Although not statistically significant, this borderline sig-
nificance warrants a closer look. Even more interesting,
is the information that of the 24 symptomatic respond-
ents who checked at least 1 GI illness, 16 checked 2, 10
checked 3, 8 checked 4, 6 checked 5, and 3 checked 6.
These data taken together with the “overall health”
question beg for additional research with a larger
group of patients and a longer list of illnesses. There
may be strong connections between GI, other illnesses
and ABS that have not yet been identified.
The significant differences demonstrated in the
General Diet Information section are interesting in
that we found people with ABS consume more water,
less tea and coffee, and fewer dairy products and candy
than the control group. Other studies have shown that
people with ABS tend to crave sugar and carbohydrates
and have reported “binging” on sugary foods.4,5 These
same studies in addition to the case studies of ABS all
recommend low carbohydrate or low glycemic index
diets during treatment. Our data may reflect the attempt
to control symptoms of ABS once becoming aware of
dietary triggers. In conversations with ABS patients,
many of them report a history of high-carbohydrate,
high-sugar diets but then drastically changing their
diets to low-carb once they became aware their symp-
toms are diet-related.
The same could be said of our findings that those with
a history of ABS tend to eat out less and rely more on
food prepared at home and avoid eating starchy foods
than the control group. Other studies of ABS, gut dys-
biosis, and IBS support the importance of diet in con-
trolling symptoms.8,9,34,35
The most interesting section of the survey data is the
Health History section that reveals those with ABS expe-
rience food sensitivities at a higher rate than the control
group. Our data correlate with other studies demonstrat-
ing links between ABS and food sensitivities, IBS with
food sensitivities, and intestinal permeability with food
sensitivities and depression.4,36,37
This section also found that patients with ABS were
diagnosed with higher than normal yeast in their GI
tract. This correlates with many other research studies
that verify patients with ABS have yeast overgrowth in
various parts of their GI system.2,3,8–10,21
Lastly, we found the ABS group had a longer use of
antibiotics for acne than those in the control group
(P¼ .03). The theory of a gut dysbiosis severe enough
to cause intoxication has long rested on the fact that
antibiotics are known to disturb the gut microbiota.
Although other research has not specifically reported
on long-term antibiotic use for acne, numerous other
reports support the fact that antibiotic use disturbs the
GI system and can lead to yeast overgrowth.38,39
Limitations
There are several limitations to our study. First, we used
a convenience sample of patients that the coauthors
knew had ABS and their family members. Second,
many of the survey questions are subjective and are
thus at risk of being answered inaccurately. Third, it
was a seemingly small sample size but considering how
rare ABS is, we felt fortunate to have as many partic-
ipants as we did. However, because our analysis con-
tained patients from 4 continents and our response
rate was 88%, our results can be generalized to the grow-
ing field of ABS.
Conclusion and Recommendations
ABS is affecting people worldwide. Very little is known
about the lifestyle, health, diet, and medical history of
ABS patients. Using a nationwide survey of ABS and
non-ABS patients, our research showed statistically sig-
nificant differences in 14 questions between ABS and
non-ABS patients, which we believe are important ele-
ments for future research in ABS. The findings in this
case–control study give insights into common factors
experienced by people with ABS.
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